Xtant Medical Holdings Inc (XTNT)
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
$0.38-5.21%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · XTNT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 109.5 | 133.9 | 117.3 | 91.3 | 58.0 | 55.3 | 53.3 | 64.7 | 72.2 | 82.6 | 90.0 | 59.3 | 35.3 | 33.1 | 33.0 | 30.1 |
| Total Revenues | — | — | — | — | — | — | 53.3 | 64.7 | 72.2 | 82.6 | 90.0 | 59.3 | 35.3 | 33.1 | 33.0 | 30.1 |
| Cost of Revenues | 44.5 | 49.7 | 49.1 | 35.8 | 25.8 | 22.8 | 18.9 | 22.2 | 28.7 | 32.5 | 27.7 | 20.3 | 13.0 | 14.2 | 10.3 | — |
| Gross Profit | 65.0 | 84.3 | 68.2 | 55.5 | 32.1 | 32.5 | 34.4 | 42.5 | 43.5 | 50.1 | 62.3 | 39.1 | 22.3 | 18.9 | 22.6 | 21.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 2.2 | 2.1 | 2.4 | 1.3 | 0.9 | 0.9 | 0.7 | 0.9 | 1.7 | 2.4 | 3.4 | 2.5 | 1.4 | — | — | — |
| Operating Income | (10.5) | 7.3 | (12.1) | (10.2) | (6.8) | (3.9) | (0.8) | (2.3) | (60.1) | (37.8) | (7.5) | (12.1) | (6.3) | (9.0) | (4.9) | (6.5) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 3.7 | 4.2 | 2.9 | 1.7 | 1.0 | 6.0 | 5.8 | 10.1 | 14.7 | 12.3 | 7.7 | 5.7 | 4.7 | 1.9 | 1.2 |
| Interest & Investment Income | — | 0.1 | — | 0.1 | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | 2.8 | 1.7 | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 1.3 | (0.3) | (4.2) | 9.1 | (1.7) | (1.0) | (6.0) | (5.9) | (10.0) | (14.6) | (11.9) | (7.6) | (4.2) | (3.7) | (2.8) | 3.4 |
| Asset Writedown | — | — | — | — | — | — | — | — | 48.1 | 17.6 | 0.0 | 0.2 | 0.9 | 0.7 | — | — |
| EBT, Incl. Unusual Items | (9.2) | 7.0 | (16.3) | (1.0) | (8.4) | (4.8) | (6.7) | (8.1) | (70.1) | (52.4) | (19.4) | (19.7) | (10.5) | (12.7) | (7.7) | (3.0) |
| Income Tax Expense | 1.9 | 2.0 | 0.2 | (1.7) | 0.1 | — | 0.3 | 0.1 | — | 0.0 | 0.1 | (17.5) | 0.0 | 0.0 | — | — |
| Net Income | ||||||||||||||||
| Net Income | (16.1) | 5.0 | (16.4) | 0.0 | (8.5) | (4.8) | (7.0) | (8.2) | (70.1) | (52.4) | (19.5) | (2.2) | (10.5) | (12.7) | (7.7) | (3.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.11) | 0.04 | (0.12) | 0.01 | (0.09) | (0.06) | (0.25) | (0.63) | (5.97) | (34.76) | (18.46) | (0.24) | (1.76) | (2.80) | (0.18) | (0.08) |
| Diluted EPS | (0.11) | 0.03 | (0.12) | 0.01 | (0.09) | (0.06) | (0.25) | (0.63) | (5.97) | (34.76) | (18.46) | (0.24) | (1.76) | (2.80) | (0.18) | (0.08) |
| Revenue per Share | 0.78 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 140.3 | 139.5 | 133.7 | 119.1 | 94.1 | 85.5 | 28.5 | 13.2 | 11.7 | 1.5 | 1.1 | 9.1 | 6.0 | 4.5 | 42.4 | 38.9 |
| Diluted Weighted Avg Shares | 140.3 | 150.0 | 133.7 | 126.8 | 94.1 | 85.5 | 28.5 | 13.2 | 11.7 | 1.5 | 1.1 | 9.1 | 6.0 | 4.5 | 42.4 | 38.9 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 12.5 | (7.9) | (7.0) | (5.5) | (2.5) | 1.3 | 0.9 | (56.0) | (32.3) | (2.6) | (8.3) | (6.0) | (8.6) | (4.5) | (6.1) |
| EBIT | (10.5) | 7.3 | (12.1) | (10.2) | (6.8) | (3.9) | (0.8) | (2.3) | (60.1) | (37.8) | (7.5) | (12.1) | (6.3) | (9.0) | (4.9) | (6.5) |
| Effective Tax Rate | -20.5% | — | — | 163.6% | -0.8% | — | -4.4% | -1.2% | — | 0.0% | -0.3% | 89.0% | 0.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.